J

Julian D. Gillmore

Alnylam Pharmaceuticals (United States)

ORCID: 0000-0001-6174-9232

Publishes on Amyloidosis: Diagnosis, Treatment, Outcomes, Parathyroid Disorders and Treatments, Alzheimer's disease research and treatments. 569 papers and 35.1k citations.

PubIndex Score98Top 2%How it's scored

569Publications

35.1kTotal Citations

First publication: 1962First senior author: 2000

Amyloidosis: Diagnosis, Treatment, Outcomes Parathyroid Disorders and Treatments Alzheimer's disease research and treatments Dermatological and Skeletal Disorders Neuroendocrine Tumor Research Advances

Top publicationsby citations

Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis

Julian D. Gillmore, Philip N. Hawkins, Matthew J. Maurer et al.|Circulation|2016

Cited by 2k

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

Pablo García‐Pavía, Aleš Linhart, Claudio Rapezzi et al.|European Heart Journal|2021

Cited by 1.1k

Systemic amyloidosis

Ashutosh Wechalekar, Philip N. Hawkins, Julian D. Gillmore|The Lancet|2015

Cited by 984

A new staging system for cardiac transthyretin amyloidosis

Julian D. Gillmore, Philip N. Hawkins, Thibaud Damy et al.|European Heart Journal|2017

Cited by 740

Misdiagnosis of Hereditary Amyloidosis as AL (Primary) Amyloidosis

Helen J. Lachmann, Philip N. Hawkins, Susanne E. Booth et al.|New England Journal of Medicine|2002

Cited by 686